Figure 3.

Distribution of neutralisation activity in three samples sets. Numbers of patients showing different degrees (>70% , 50-70% and <50%) of neutralisation of XMRV infectivity are shown for the 1/40 and 1/80 serum dilutions. A, Total BLT cohort (n = 226); B, SGUL CFS cohort (n = 142); C, SGUL control blood donor cohort (n = 157).

Groom et al. Retrovirology 2010 7:10   doi:10.1186/1742-4690-7-10
Download authors' original image